Current and historical gross, operating and net profit margins for Bristol-Myers Squibb (BMY) over the last 10 years. The current net profit margin for Bristol-Myers Squibb as of June 30, 2018 is 1.74%.
|Bristol-Myers Squibb Annual Profit Margin Summary
|Bristol-Myers Squibb Quarterly Profit Margin Summary
||Large Cap Pharmaceutical
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.